Co-Editor-in-Chief Dr. Millie Long interviews Dr. Eric S. Orman on his recently published article discussing the incidence, causes, and risk factors for preventable readmission in cirrhosis patients. (10:47)

Co-Editor-in-Chief Jasmohan S. Bajaj, MD, MS, FACG interviews Scott Tenner, MD, MPH, JD, FACG about the recently published ACG Guideline on the management of acute pancreatitis.(18:47)

Co-Editor-in-Chief Jasmohan S. Bajaj, MD, MS, FACG interviews Vijay H. Shah, MD, FACG about the recently published ACG Guideline on the management of alcohol-associated liver disease. (16:32)

Co-Editor-in-Chief Millie Long, MD, MPH, FACG interviews associate editor Christopher Ma, MD, MPH about post-endoscopy care for food bolus impaction. (08:41)

Co-Editor-in-Chief Millie Long, MD, MPH, FACG interviews William D. Chey, MD, FACG about the updated AGA-ACG Guideline on the management of chronic idiopathic constipation. (25:41)

Co-Editor-in-Chief Jasmohan S. Bajaj, MD, MS, FACG interviews Alexandra Shingina, MD, MSc about the recently published ACG Guideline on the diagnosis and management of acute liver failure. (18:20)

Co-Editor-in-Chief Millie Long, MD, MPH, FACG interviews Alberto Rubio-Tapia, MD about the updated ACG Guideline on the diagnosis and management of celiac disease. (10:46)

Co-Editor-in-Chief Jasmohan Bajaj, MD, MS, FACG interviews Joseph B. Elmunzer, MD, MSc on the recently published ACG Clinical Guideline on the diagnosis and management of biliary strictures (15:26).

Co-Editor-in-Chief Dr Millie Long interviews Dr. Neil Sengupta about the updated ACG Guideline on the management of patients with acute lower gastrointestinal bleeding.(14:57)

Co-Editor-in-Chief Jasmohan Bajaj, MD, MS, FACG interviews Brian C. Jacobson, MD, MPH, FACG on the recently published ACG Clinical Guideline for the diagnosis and management of gastrointestinal subepithelial lesions. (17:49)

Co-Editor-in-Chief Dr Millie Long interviews Dr Brennan Spiegel of Cedars-Sinai Medical Center in Los Angeles on his new hypothesis that seeks to accommodate the manifold theories, clinical symptoms, somatic comorbidities, neuropsychological features, and treatment outcomes of IBS by describing the syndrome in relation to a principal force of human evolution: gravity. (20:33)

AJG Co-Editor-in-Chief Millie Long and Dr Phillip Gu from Cedars-Sinai Medical System in Los Angeles, California discuss a new study on whether or not obesity is associated with an increased risk of unplanned healthcare utilization and serious infections.(09:04)

Mark Pimentel, MD, FACG, discusses a smartphone application that uses artificial intelligence to help subjects self-report stool form. A novel smartphone application can determine BSS and other visual stool characteristics with high accuracy compared with the 2 expert gastroenterologists. Moreover, trained AI was superior to subject self-reporting of BSS. AI assessments could provide more objective outcome measures for stool characterization in gastroenterology. (10:49)

Co-Editor-in-Chief Millie Long, MD, MPH, FACG interviews Nicholas Shaheen, MD, MPH discuss the recently updated ACG Guideline on the Diagnosis and Management of Barrett's Esophagus. Dr. Shaheen highlights changes in the new guideline including broadening of acceptable screening modalities for BE to include nonendoscopic methods, liberalized intervals for surveillance of short-segment BE, and volume criteria for endoscopic therapy centers for BE. (19:44)

Co-Editor-in-Chief Jasmohan Bajaj, MD, FACG and Douglas A. Simonetto, MD discuss the newly published article "Development of the AI-Cirrhosis-ECG Score: An Electrocardiogram-Based Deep Learning Model in Cirrhosis." This study aimed to develop a proof-of-concept deep learning-based artificial intelligence model that could detect cirrhosis-related signals on ECG and generate an AI-Cirrhosis-ECG, or ACE, score to correlate with disease severity. (12:59)

Binu V. John, MD, MPH joins Co-Editor-in-Chief Brian Lacy, MD, PhD, FACG to discuss the retrospective study conducted through the US Veterans Administration which examined the association of ursodeoxycholic acid liver-related death, hepatic decompensation, and hepatocellular carcinoma in patients with primary biliary cirrhosis. (23:28)